市场调查报告书
商品编码
1494558
北美自动体外心臟去颤器市场预测至 2030 年 - 区域分析 - 按类型(全自动体外心臟去颤器和半自动体外心臟去颤器)和最终用户(医院和诊所、家庭护理等)North America Automated External Defibrillators Market Forecast to 2030 - Regional Analysis - by Type (Fully-Automated External Defibrillators and Semi- Automated External Defibrillators) and End User (Hospitals & Clinics, Homecare, and Others) |
北美自动体外心臟去颤器市场预计将从2022年的6.8103亿美元成长到2030年的9.8355亿美元。
心血管疾病盛行率的增加推动北美自动体外心臟去颤器市场
心血管疾病(CVD)是全球发病率和死亡率的主要原因。根据美国疾病管制与预防中心 (CDC) 的数据,2021 年,每 6 名心血管疾病死亡者中就有 1 人死于中风。世界卫生组织(WHO)报告称,全球每年有1790万人死于CVD,占所有死亡病例的32%。此外,五分之四的心血管疾病相关死亡是由于心臟病和中风造成的。不健康的生活习惯,包括不良饮食、肥胖、缺乏运动、吸烟和过量饮酒,是心血管疾病的主要原因。心血管疾病病例激增导致对除颤器的需求量很大,作为医院心血管疾病患者復苏和护理的重要工具。随着国家医疗保健支出和各地区家庭可支配收入的增加,用于治疗心血管疾病的除颤器的使用预计会增加。此外,在对除颤器作为医院重要仪器的需求如此之高的情况下,自动体外心臟去颤器由于其在心臟骤停 (SCA) 患者復苏方面的适用性增强而获得了显着的关注。因此,心血管疾病发生率的不断上升推动了医院、家庭和其他医疗机构对去颤器(包括自动体外心臟去颤器)的需求。
北美自动体外心臟去颤器市场概况
北美自动体外心臟去颤器市场分为美国、加拿大和墨西哥。北美自动体外心臟去颤器市场分为美国、加拿大和墨西哥。美国是自动体外除颤器的最大市场。这个市场的主要动力是呼吸系统疾病的广泛增加、大量糖尿病人口以及人们对呼吸系统疾病认识的提高。由于心血管疾病(CVD)发病率增加、人们对自动除颤器的认识不断提高、该地区领先製药公司的存在等多种因素,预计美国将成为自动体外除颤器的最大市场。医疗保健基础设施的存在。此外,技术进步导致了各种新型除颤器的开发。
冠状动脉疾病(CAD)是已开发国家发病和死亡的主要原因之一。根据疾病管制中心的研究,冠心病每年导致约 6,10,000 人死亡(估计占死亡人数的四分之一),使其成为美国的首要死因。此外,预计 2012 年至 2050 年间,65 岁及以上的人口数量将会增加,因此需要更深入了解心血管疾病对老年人的影响。
此外,人们心臟病盛行率的上升也促进了自动体外去颤器市场的成长。根据美国心臟协会 (AHA) 的《2019 年心臟病和中风统计》,美国约有 1.215 亿成年人患有心血管疾病,每年有 805,000 名美国人遭受心臟病发作。此外,根据 CDC 的数据,美国每年约有 7,95,000 人患有脑血管中风。根据克莱蒙特研究生大学 2019 年发布的 DIL(心臟衰竭患者对话代理),与心血管疾病和中风治疗相关的间接和直接成本预计将超过 3,297 亿美元,其中包括医疗支出和生产力损失。因此,患者的治疗费用增加。
高血压是心臟病、中风和心臟骤停的主要危险因素之一,但它是可以治癒的。根据美国心臟协会2023年的报告,大约50%的20岁以上美国人,即超过1.22亿人患有高血压。预计未来几年高血压盛行率将会上升;因此,预计未来心血管疾病的发生率也可能会增加。
北美自动体外心臟去颤器市场收入及 2030 年预测(百万美元)
北美自动体外心臟去颤器市场细分
北美自动体外心臟去颤器市场按类型、最终用户和国家/地区进行细分。
根据类型,北美自动体外心臟去颤器市场分为全自动体外心臟去颤器和半自动体外心臟去颤器。 2022 年,全自动体外心臟去颤器细分市场在北美自动体外心臟去颤器市场中占据更大份额。
根据最终用户,北美自动体外心臟去颤器市场分为医院和诊所、家庭护理等。 2022 年,医院和诊所细分市场在北美自动体外心臟去颤器市场中占据最大份额。
根据国家/地区,北美自动体外心臟去颤器市场分为美国、加拿大和墨西哥。 2022 年,美国主导北美自动体外心臟去颤器市场。
旭化成公司、皇家飞利浦公司、Mediana 有限公司、日本光电公司、Schiller AG、深圳迈瑞生物医疗电子有限公司和史赛克公司是北美自动体外除颤器市场上的一些领先公司。
The North America automated external defibrillators market is expected to grow from US$ 681.03 million in 2022 to US$ 983.55 million by 2030. It is estimated to record a CAGR of 4.7% from 2022 to 2030.
Increasing Prevalence of Cardiovascular Diseases Drives North America Automated External Defibrillators Market
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. As per the Centers for Disease Control and Prevention (CDC), in 2021, 1 in 6 deaths from cardiovascular disease was due to stroke. The World Health Organization (WHO) reported that 17.9 million die globally due to CVD every year, i.e., 32% of all mortality cases. Furthermore, 4 out of 5 CVD-related mortalities are due to heart attacks and strokes. Unhealthy lifestyle habits, including poor diet, obesity, physical inactivity, tobacco consumption, and excess alcohol consumption, are the leading causes of CVDs. The surging cases of CVDs result in high demand for defibrillators as an essential tool for the resuscitation and care of CVD patients in hospitals. With a rise in national healthcare expenditures and disposable household incomes in various regions, the use of defibrillators is expected to increase in order to manage CVD. Furthermore, amid such high demands for defibrillators as a vital instrument in hospitals, automated external defibrillators are gaining notable traction owing to their enhanced suitability in the resuscitation of persons having sudden cardiac arrest (SCA). Thus, the growing incidence of CVDs drives the demand for defibrillators, including automated external defibrillators, in hospitals, homes, and other healthcare settings.
North America Automated External Defibrillators Market Overview
The Automated External Defibrillator market in North America is segmented into the US, Canada, and Mexico. The Automated External Defibrillator market in North America is segmented into the US, Canada, and Mexico. The US is the largest market for automated external defibrillator. The market is prominently driven by an extensive rise in respiratory diseases, a big pool of diabetic population, increase in awareness about respiratory diseases among the population. The US is projected to be the largest market for automated external defibrillators due to multiple factors such as an increase in the incidence of cardiovascular disease (CVDs), rising awareness about the presence of automatic defibrillators, the presence of leading pharmaceutical companies in this region, and the existence of fully developed healthcare infrastructure. Moreover, technological advancements have resulted in the development of various novel defibrillators.
Coronary artery disease (CAD) is among the leading causes of morbidity and mortality in developed countries. According to the Centers for Disease Control research, CAD accounts for ~6,10,000 deaths annually (estimated 1 in 4 deaths), which makes it the leading cause of death in the US. Furthermore, the population of people aged 65 and above is predicted to increase between 2012 and 2050, which boosts the need for a greater understanding of the impact of cardiovascular diseases on older adults.
In addition, the rising prevalence of cardiac conditions among people contributes to the automated external defibrillator market growth. Per the American Heart Association's (AHA) "heart disease and Stroke Statistics 2019", approximately 121.5 million adults in the US are suffering from CVDs, and every year 8,05,000 Americans suffer from a heart attack. In addition, as per the CDC, ~7,95,000 people in the US suffer from cerebrovascular stroke every year. As per DIL-a Conversational Agent for Heart Failure Patients by Claremont Graduate University published in 2019-the indirect and direct costs associated with the treatment of cardiovascular diseases and stroke are anticipated to be more than US$ 329.7 billion, which includes both health expenditures and productivity loss. Therefore, the cost of the treatments increases for the patients.
Hypertension is one of the major risk factors for heart diseases, strokes, and cardiac arrests, but it is highly treatable. According to a 2023 report from the American Heart Association, approximately 50% of Americans aged 20 years and above, i.e., more than 122 million people, have high blood pressure. The prevalence of hypertension is expected to rise in the coming years; therefore, it is anticipated that the incidences of cardiovascular diseases are also likely to increase in the future.
North America Automated External Defibrillators Market Revenue and Forecast to 2030 (US$ Million)
North America Automated External Defibrillators Market Segmentation
The North America automated external defibrillators market is segmented into type, end user, and country.
Based on type, the North America automated external defibrillators market is bifurcated into fully-automated external defibrillators and semi- automated external defibrillators. The fully-automated external defibrillators segment held a larger share of the North America automated external defibrillators market in 2022.
Based on end user, the North America automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. The hospitals & clinics segment held the largest share of the North America automated external defibrillators market in 2022.
Based on country, the North America automated external defibrillators market is segmented into the US, Canada, and Mexico. The US dominated the North America automated external defibrillators market in 2022.
Asahi Kasei Corp, Koninklijke Philips NV, Mediana Co Ltd, Nihon Kohden Corp, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Stryker Corp are some of the leading companies operating in the North America automated external defibrillators market.